Exquisite sensitivity of TP53 mutant breast cancers to dose-dense chemotherapy
Lehmann-Che, Jacqueline, Turpin, Elisabeth, Bertheau, Philippe, Espié, Marc, de Thé, Hugues
Published in M.S. Médecine sciences (01.11.2007)
Published in M.S. Médecine sciences (01.11.2007)
Get full text
Journal Article
RXR, a key member of the oncogenic complex in acute promyelocytic leukemia
Halftermeyer, Juliane, Le Bras, Morgane, De Thé, Hugues
Published in M.S. Médecine sciences (01.11.2011)
Published in M.S. Médecine sciences (01.11.2011)
Get full text
Journal Article
RXR, un cofacteur essentiel à la transformation dans les leucémies aiguës promyélocytaires
Halftermeyer, Juliane, Le Bras, Morgane, De Thé, Hugues
Published in M.S. Médecine sciences (01.11.2011)
Published in M.S. Médecine sciences (01.11.2011)
Get full text
Journal Article
A PHARMACEUTICAL COMPOSITION COMPRISING AN ARSENIC COMPOUND, AN INDUCTOR OF TYPE-1 IFN AND A PROTEIN KINASE INHIBITOR FOR TREATING CANCER
HADDAD, Rima, RENOU, Laurent, NAGUIBNEVA, Irina, PFLUMIO, Françoise, BALLERINI, Paola, DE THE, Hugues, LALLEMAND-BREITENBACH, Valérie
Year of Publication 18.11.2021
Get full text
Year of Publication 18.11.2021
Patent